Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains-Reference-Cited by-同舟云学术

Inhibition of Lapatinib-Induced Kinome Reprogramming in ERBB2-Positive Breast Cancer by Targeting BET Family Bromodomains

Published:2015-04 Issue:3 Volume:11 Page:390-404
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Stuhlmiller Timothy J.,Miller Samantha M.,Zawistowski Jon S.,Nakamura Kazuhiro,Beltran Adriana S.,Duncan James S.,Angus Steven P.,Collins Kyla A.L.,Granger Deborah A.,Reuther Rachel A.,Graves Lee M.,Gomez Shawn M.,Kuan Pei-Fen,Parker Joel S.,Chen Xin,Sciaky Noah,Carey Lisa A.,Earp H. Shelton,Jin Jian,Johnson Gary L.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference22 articles.

1. Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer;Allen-Petersen;Oncogene,2014

2. Resiliency and vulnerability in the HER2-HER3 tumorigenic driver;Amin;Sci. Transl. Med.,2010

3. Switching addictions between HER2 and FGFR2 in HER2-positive breast tumor cells: FGFR2 as a potential target for salvage after lapatinib failure;Azuma;Biochem. Biophys. Res. Commun.,2011

4. AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity;Chandarlapaty;Cancer Cell,2011

5. BET bromodomain inhibition as a therapeutic strategy to target c-Myc;Delmore;Cell,2011

Cited by 254 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human Blood Serum Antagonizes Effects of EGFR/HER2-Targeted Drug Lapatinib on Squamous Carcinoma SK-BR-3 Cell Growth and Gene Expression;Биохимия;2024-09-14

2. Circulating tumor cells: from new biological insights to clinical practice;Signal Transduction and Targeted Therapy;2024-09-02

3. FAM122A ensures cell cycle interphase progression and checkpoint control by inhibiting B55α/PP2A through helical motifs;Nature Communications;2024-07-10

4. Impact of Abl2/Arg deficiency on anxiety and depressive behaviors in mice;Behavioural Brain Research;2024-06

5. Rational design of HER2-targeted combination therapies to reverse drug resistance in fibroblast-protected HER2+ breast cancer cells;2024-05-19